BIRC5 and urinary bladder carcinoma: 24820432 24820432 Wang Y, Tan H, Xu D, Ma A, Zhang L, Sun J et al (2014) The combinatory effects of PPAR‐γ agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cells.